Investigating how specific signaling pathways affect insulin production in diabetes
The role of G protein-dependent and -independent EP3 signaling in beta-cell compensation and diabetes
This study is looking at how specific signals in the cells that make insulin can help improve insulin production and increase the number of healthy insulin-producing cells, which could lead to better treatments for people with type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11075871 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of certain signaling pathways in pancreatic beta-cells, which are crucial for insulin production. By examining the effects of the EP3 receptor and its associated G protein, the study aims to identify new methods to enhance insulin secretion and increase the number of functional beta-cells in individuals with type 2 diabetes. The approach involves both cellular and molecular techniques to explore how these pathways can be targeted for better diabetes treatment. Patients may benefit from potential new therapies that improve insulin function and overall glucose management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes, particularly those who may not respond well to current treatments.
Not a fit: Patients with type 1 diabetes or those whose diabetes is not linked to beta-cell dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that enhance insulin production and improve blood sugar control in diabetes patients.
How similar studies have performed: Previous research has shown promising results in targeting similar signaling pathways to improve beta-cell function, indicating potential for success in this approach.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Kimple, Michelle E — University of Wisconsin-Madison
- Study coordinator: Kimple, Michelle E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.